The global spatial genomics and transcriptomics market is expected to grow at a CAGR of around 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for personalized medicine, growing number of research studies in the field of spatial genomics and transcriptomics, and technological advancements in the field.
The global spatial genomics and transcriptomics market is segmented on the basis of type into instruments, consumables, software; on the basis of application into academic research and pharmaceutical manufacturer; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The North American region dominates this market with a share close to 40%. This can be attributed to high adoption rates for personalized medicine in this region.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of this market.
- Increasing government funding for research and development in this field is also driving the growth of this market.
- Increasing demand for personalized medicine.
- Technological advancements in sequencing technologies are expected to drive the growth of this market.
Industry Growth Insights published a new data on “Spatial Genomics & Transcriptomics Market”. The research report is titled “Spatial Genomics & Transcriptomics Market research by Types (Instruments, Consumables, Software), By Applications (Academic Research, Pharmaceutical Manufacturer, Others), By Players/Companies NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group, CARTANA, Advanced Cell Diagnostics, 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Spatial Genomics & Transcriptomics Market Research Report
By Type
Instruments, Consumables, Software
By Application
Academic Research, Pharmaceutical Manufacturer, Others
By Companies
NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group, CARTANA, Advanced Cell Diagnostics, 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Spatial Genomics & Transcriptomics Market Report Segments:
The global Spatial Genomics & Transcriptomics market is segmented on the basis of:
Types
Instruments, Consumables, Software
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research, Pharmaceutical Manufacturer, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- NanoString Technologies
- Seven Bridges Genomic
- Horizon Discovery Group
- CARTANA
- Advanced Cell Diagnostics
- 10x Genomics
- Dovetail Genomics
- Illumina
- S2 Genomics
Highlights of The Spatial Genomics & Transcriptomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Instruments
- Consumables
- Software
- By Application:
- Academic Research
- Pharmaceutical Manufacturer
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Spatial Genomics & Transcriptomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Spatial Genomics and Transcriptomics are two different but complementary fields of study that use genomic and transcriptomic data to understand the spatial organization of genes, gene expression, and other molecular features in cells.
Some of the major players in the spatial genomics & transcriptomics market are NanoString Technologies, Seven Bridges Genomic, Horizon Discovery Group, CARTANA, Advanced Cell Diagnostics, 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics.
The spatial genomics & transcriptomics market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Spatial Genomics & Transcriptomics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Spatial Genomics & Transcriptomics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Spatial Genomics & Transcriptomics Market - Supply Chain
4.5. Global Spatial Genomics & Transcriptomics Market Forecast
4.5.1. Spatial Genomics & Transcriptomics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Spatial Genomics & Transcriptomics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Spatial Genomics & Transcriptomics Market Absolute $ Opportunity
5. Global Spatial Genomics & Transcriptomics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
5.3.1. Instruments
5.3.2. Consumables
5.3.3. Software
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Spatial Genomics & Transcriptomics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
6.3.1. Academic Research
6.3.2. Pharmaceutical Manufacturer
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Spatial Genomics & Transcriptomics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Spatial Genomics & Transcriptomics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Spatial Genomics & Transcriptomics Demand Share Forecast, 2019-2026
9. North America Spatial Genomics & Transcriptomics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
9.4.1. Academic Research
9.4.2. Pharmaceutical Manufacturer
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
9.7.1. Instruments
9.7.2. Consumables
9.7.3. Software
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Spatial Genomics & Transcriptomics Demand Share Forecast, 2019-2026
10. Latin America Spatial Genomics & Transcriptomics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
10.4.1. Academic Research
10.4.2. Pharmaceutical Manufacturer
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
10.7.1. Instruments
10.7.2. Consumables
10.7.3. Software
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Spatial Genomics & Transcriptomics Demand Share Forecast, 2019-2026
11. Europe Spatial Genomics & Transcriptomics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
11.4.1. Academic Research
11.4.2. Pharmaceutical Manufacturer
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
11.7.1. Instruments
11.7.2. Consumables
11.7.3. Software
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Spatial Genomics & Transcriptomics Demand Share, 2019-2026
12. Asia Pacific Spatial Genomics & Transcriptomics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
12.4.1. Academic Research
12.4.2. Pharmaceutical Manufacturer
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
12.7.1. Instruments
12.7.2. Consumables
12.7.3. Software
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Spatial Genomics & Transcriptomics Demand Share, 2019-2026
13. Middle East & Africa Spatial Genomics & Transcriptomics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Application
13.4.1. Academic Research
13.4.2. Pharmaceutical Manufacturer
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Spatial Genomics & Transcriptomics Market Size and Volume Forecast by Type
13.7.1. Instruments
13.7.2. Consumables
13.7.3. Software
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Spatial Genomics & Transcriptomics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Spatial Genomics & Transcriptomics Market: Market Share Analysis
14.2. Spatial Genomics & Transcriptomics Distributors and Customers
14.3. Spatial Genomics & Transcriptomics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. NanoString Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Seven Bridges Genomic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Horizon Discovery Group
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CARTANA
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Advanced Cell Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. 10x Genomics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Dovetail Genomics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Illumina
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. S2 Genomics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
